The high-fidelity image of the Apple Watch Series 10’s rear sensor renders a sleek and modern design.
The long-awaited blood oxygen level and sleep apnea features on the Apple Watch may not materialize in Apple Watch Series 9 or earlier.
Rumors persist that Apple will introduce a blood-glucose monitoring feature on its Apple Watch Series 10, potentially revolutionizing diabetes management for millions. The possibility of incorporating sleep apnea features has also been considered.
Regrettably, Apple may have faced numerous challenges in introducing options for its 2024 generation.
Apple’s efforts to accurately measure blood pressure, commonly referred to as hypertension, have fallen short of meeting the company’s standards. Reports suggest that problems persist with the Apple Watch Series 10’s performance operating seamlessly under its revamped design.
However, while consumers may expect comprehensive blood glucose level monitoring capabilities, Apple’s technology falls short in this regard. Instead of simply serving as a substitute, this technology will scrutinize whether an individual’s blood pressure exceeds their long-established norm, prompting only a notification to the individual.
Sleep Apnea
The performance of sleep apnea sufferers is being hindered by a significant non-medical factor. Apple’s legal battle with Masimo Corporation over intellectual property rights related to blood oxygen saturation detection technology has resulted in a temporary limitation on the company’s ability to measure this crucial metric.
To enable sleep apnea tracking on the Apple Watch, Apple must either resolve the pending lawsuit or develop a workaround for the existing intellectual property issue?
It’s possible that Apple might incorporate advanced features into the Apple Watch Series 10, but deliberately disable them at launch to create a buzz and encourage users to explore and learn about the new capabilities. If Apple is granted the opportunity, they could potentially activate it at a later date, subject to the outcome of the lawsuit and any subsequent approvals allowing the technology’s utilization.
An even bigger objective forward
As the Apple Watch Series 10 approaches, a key feature may prove an even greater challenge for Apple to overcome.
Has long been touted as being on the cusp of a breakthrough, yet it remains stuck in development limbo, with little indication that its arrival at our fingertips is imminent anytime soon. Due to the invasiveness required for glucose monitoring, it is challenging to carry out non-invasive tests that do not involve direct blood sampling?
Notwithstanding, a recent Sunday report revealed that Apple has successfully achieved several key milestones in its ongoing improvement efforts. The performer’s imminent arrival is signified by this cue, leaving room neither for speculation nor uncertainty about when exactly that will occur.
